This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Allergan, Warner Chilcott seek emergency stay in Asacol antitrust case

( January 19, 2018, 23:31 GMT | Official Statement) -- MLex Summary: Allergan and Warner Chilcott have asked the US Court of Appeals for the First Circuit to grant an emergency stay in a case accusing them of unlawfully delaying the entry of generic versions of the ulcerative colitis drug Asacol. They are seeking to stay the jury trial pending an appeal of an order that granted plaintiffs class certification.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections